Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

The global research agenda includes 33 research priorities for bacterial and fungal infections and 7 for drug-resistant ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

A study reveals AI's role in identifying antimicrobial compounds for tuberculosis, enhancing drug development through ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering ...

Bacille Calmette-Guérin (BCG) is the vaccine for tuberculosis, but according to Collins, it is not routinely given in the U.S. According to the CDC, this is due to several reasons, including the mixed ...